07:00 , Apr 16, 2001 |  BioCentury  |  Finance

Ebb & Flow

U.K. investors still are willing to dole out money only in dribs and drabs, as evidenced by the recent experiences of transgenics company PPL Therapeutics and cardiac device company Aortech . Thus for the foreseeable...